Transplant Proc. 2003 May;35(3):1093-5. Homocysteine levels in pediatric renal transplant recipients. Mota C, Fonseca I, Santos MJ, Costa T, Faria MS, Henriques AC, Sarmento AM, Pereira E, Pereira M. Department of Paediatric Nephrology, Maria Pia Children's Hospital, R. da Boavista, 827, 4050-111, Porto, Portugal. ccmotacosta@hotmail.com PMID: 12947872 [PubMed - indexed for MEDLIN
Plasma hyperhomocysteinemia (HHcy) is considered a risk factor for chronic allograft dysfunction (CA...
Hyperhomocysteinemia is a well-known independent risk factor for cardiovascular disease and is a pre...
CARDIOVASCULAR disease (CVD) is a major causeof morbidity and mortality after renal transplantation ...
Cardiovascular disease (CVD) is a major cause of morbidity and mortality after renal transplantation...
PURPOSE: Hyperhomocyst(e)inaemia is an important risk factor for atherosclerosis, which is currently...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Established cardiovascular risk factors such as hypercholesterolemia have been claimed to adversely ...
Serum total homocysteine concentration before and after renal transplantation.BackgroundHyperhomocys...
Moderate hyperhomocysteinemia, an independent cardiovascular risk factor, has been reported in renal...
Background-Kidney transplant recipients, like other patients with chronic kidney disease, experience...
Liver transplant recipients have an increased risk for cardiovascular disease because of a hi...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Aim-To study the effect of folate treatment on hyperhomocysteinaemia and the effect of 5,10-methyle...
Homocysteine, its metabolites, and B-group vitamins in renal transplant patients.BackgroundIncreased...
Impact of Homocysteinemia on Long-Term Renal Transplant Survival I. Fonseca, L. Martins, J. Quei...
Plasma hyperhomocysteinemia (HHcy) is considered a risk factor for chronic allograft dysfunction (CA...
Hyperhomocysteinemia is a well-known independent risk factor for cardiovascular disease and is a pre...
CARDIOVASCULAR disease (CVD) is a major causeof morbidity and mortality after renal transplantation ...
Cardiovascular disease (CVD) is a major cause of morbidity and mortality after renal transplantation...
PURPOSE: Hyperhomocyst(e)inaemia is an important risk factor for atherosclerosis, which is currently...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Established cardiovascular risk factors such as hypercholesterolemia have been claimed to adversely ...
Serum total homocysteine concentration before and after renal transplantation.BackgroundHyperhomocys...
Moderate hyperhomocysteinemia, an independent cardiovascular risk factor, has been reported in renal...
Background-Kidney transplant recipients, like other patients with chronic kidney disease, experience...
Liver transplant recipients have an increased risk for cardiovascular disease because of a hi...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Aim-To study the effect of folate treatment on hyperhomocysteinaemia and the effect of 5,10-methyle...
Homocysteine, its metabolites, and B-group vitamins in renal transplant patients.BackgroundIncreased...
Impact of Homocysteinemia on Long-Term Renal Transplant Survival I. Fonseca, L. Martins, J. Quei...
Plasma hyperhomocysteinemia (HHcy) is considered a risk factor for chronic allograft dysfunction (CA...
Hyperhomocysteinemia is a well-known independent risk factor for cardiovascular disease and is a pre...
CARDIOVASCULAR disease (CVD) is a major causeof morbidity and mortality after renal transplantation ...